Skip to main content
SpringerLink
Log in

Sympathomimetics and Xanthines in the Treatment of Asthma

  • Chapter
Asthma Treatment

Part of the book series: NATO ASI Series ((NSSA,volume 229))

  • 152 Accesses

Abstract

Sympathomimetics and xanthines are widely used in the treatment of both acute and chronic asthma. They are generally believed to act primarily by reversing the contraction of airway smooth muscle, although they may have additional properties that may be beneficial in the treatment of asthma (Barnes, 1990). In this review, new developments and recent insights into the place of this 2 groups of drugs in the treatment of acute and chonic asthma will be presented. For a more in depth review, the reader is reffered to several recent reviews (Tattersfield 1988, Kerrebijn 1991, Svedmyr, 1988, Pauwels 1991, Persson 1991).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersson P, Brange C, Sonmark B, Stare G, Erjefalt I, Wieslander E, Persson C.G.A., 1985, Anti-anaphylactic and anti-inflammatory effects of xanthines in the lung, In: Andersson KE, Persson CGA (eds). Anti-asthma xanthines and adenosine. Amsterdam, Excerpta, pp 187.

    Google Scholar 

  2. Arvidsson P, Larsson S, Lofdahl C-G, Melander B, Wahlander L, Svedmyr N., 1989, Formoterol, a new long-acting bronchodilator for inhalation, Eur Resp J, 2:325.

    CAS  Google Scholar 

  3. Barnes P.J., Greening A.P., Neville L, Timmers J, Poole G.W., 1982, Single-dose slow release aminophylline at night prevents nocturnal asthma, Lancet, 1:299.

    Article  PubMed  CAS  Google Scholar 

  4. Barnes P.J., 1989, A new approach to the treatment of asthma, N Engl J Med, 321:1517.

    Article  CAS  Google Scholar 

  5. Becker A.B., Simons F.E.R., 1989, Formoterol, a new long-acting selective beta2-adrenergic receptor agonist double-blind comparison with salbutamol and placebo in children with asthma, J Allergy Clin Immunol, 84:891.

    Article  PubMed  CAS  Google Scholar 

  6. Bel E.H., Zwinderman A.H., Timmers M.C., Dijkman J.H., Sterk P.J., The protective effect of a beta2-agonist on excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease, Thorax, 46:9.

    Google Scholar 

  7. Bradshow J, Buttain R.T., Coleman R.A., Jack D, Kennedy I, Cunts C.H.C., Skidmore I.F.,1987, The design of salmeterol. A long-acting selective beta2-adrenoreceptor agonist, Br J Pharmacol, 92:590P.

    Google Scholar 

  8. BRITISH THORACIC SOCIETY, 1990, Guidelines for management of asthma in adults: I-chronic persistent asthma, Br Med J, 301:651.

    Article  Google Scholar 

  9. Britton J, Hanley S.P., Garrett H.V., Hadfield J.W., Tattersfield A.E., 1988, Dose related effects of salbutamol reactivity in subjects with asthma, Thorax, 43:300.

    Article  PubMed  CAS  Google Scholar 

  10. Brenner M, Berkowitz R, Marshall N, Strunk R.C., 1988, Need for theophylline in severe steroid-requiring asthmatics, Clin Allergy, 18:143.

    Article  PubMed  CAS  Google Scholar 

  11. Cartierr, Lemaire I, L’archeveque J, Ghezzo H, Martin R.R., Malo J.L., Theophylline partially inhibits bronchoconstriction caused by inhaled histamine in subjects with asthma, J Allergy Clin Immunol, 77:570.

    Google Scholar 

  12. Chapman K.R., Bryant D., Marlin G.E., Mitchell G., Ruffin R., Inouye T., Pedersen B., Koskinen S., Osen S.S., Ringdal N., Willey R.F., Formgren H., Persson G., Kallen A., Ljungholm K., 1989, A placebo-controlled dose-response study of enprofylline in the maintenance therapy of asthma, Am Rev RespirDis, 139:688.

    CAS  Google Scholar 

  13. Clark H., Cushley M.J., Persson C.G.A., Holgate S.T., 1989, The protective effects of intravenous theophylline and enprofylline against histamine-and adenosine-5’-monophosphateprovoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma, Pulm Pharmacol, 2:147.

    Article  Google Scholar 

  14. Cockroft D.W., Murdock K.Y., Comparative effects of inhaled salbutamol, sodium cromoglycate and beclomethasoine dipropionate on allergen-induced early asthmatic responses, late asthmatic response and increased bronchial responsiveness to histamine. J Allergy Clin Immunol, 79:734.

    Google Scholar 

  15. Crescioli S., Spinazzi A., Paleari D., Pozzan M., Mapp C.E., Fabbri L.M., Theophylline inhibits early and late asthmatic reactions induced by allergens in atopic subjects with asthma, Am Rev Respir Dis, 137:A35.

    Google Scholar 

  16. Derom E.Y., Pauwels R.A., 1991, Time course of the bronchodilating effect of inhaled formoterol: a potent and long-acting sympathomimetic, Thorax (accepted).

    Google Scholar 

  17. Derom E.Y., Pauwels R.A., Van Der Straeten M.E., 1991, Duration of the protective effect of inhaled salmeterol on methacholine challenge in asthmatics, (submitted).

    Google Scholar 

  18. Dutoit J., Salome C.M., Woolcock A.J., Inhaled corticosteroids reduce the severiry of bronchial hyperesponsiveness in asthma but oral theophylline does not, 1987, Am Rev Respir Dis, 136:1174.

    Article  PubMed  CAS  Google Scholar 

  19. Fabbri L.M., Aslessandri M.V., De Marzo N., Zocca E., Paleari D., 1986, Long-lasting protective effect of slow-release theophylline on asthma induced by ultrasonically nebulized distilled water, Ann Allergy, 56:171.

    PubMed  CAS  Google Scholar 

  20. Gronneberg R., Zetterstrom O., 1990, Inhibition of anti-IgE induced skin response in normals by formoterol, a new beta2adrenoreceptor agonist, and terbutaline.

    Google Scholar 

  21. Dose response relation and duration of effect on the early wheal and flare response, Allergy, 45:334.

    Google Scholar 

  22. Effect on late phase reaction. Allergy 1990, 45: 340–346.

    Article  Google Scholar 

  23. Graff-Lonnevig V., Browaldh L., 1990, Twelve hours’bronchodilating effect of inhaled formoterol in children with asthma: a double-blind cross-over study versus salbutamol. Clin Experimental Allergy, 20:429.

    Article  CAS  Google Scholar 

  24. Hekking P.R., Maesen F., Greefhorst A., Prins J., Tan Y., Zweers P., 1990, Long-term efficacy of formoterol compared to salbutamol, Lung, S:76.

    Article  Google Scholar 

  25. Ishizaki T., Minegishi A., Morishita M., Odaijma Y., Kanagawa S., Nagai T., Yamaguchi M., 1988, Plasma catecholamine concentrations during a 72-hour aminophylline infusion in children with acute asthma, J Allergy Clin Immunology, 82:146.

    Article  CAS  Google Scholar 

  26. Karlsson J.A., Persson C.G.A., 1981, Influence of tracheal contraction on relaxant effects in vitro of theophylline and isoprenaline, Br J Pharmacol, 74:73.

    Article  PubMed  CAS  Google Scholar 

  27. Kerrebijn K.F., 1991, Beta agonists, In: Asthma. Its pathology and treatment. Ed by Kaliner MA, Barnes PJ, Persson CGA. Lung biology in health and disease, volume 49. Marcel Dekker, New York, pp 523–559.

    Google Scholar 

  28. Kraan J., Koeter G.H., V D Mark W., Sluiter H.J., De Vries K., 1985, Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma a comparison between budesonide and terbutaline, J Allergy Clin Immunol, 76:628.

    Article  PubMed  CAS  Google Scholar 

  29. Littenberg B., 1988, Aminophylline treatment in severe, acute asthma, JAMA, 259:1678.

    Article  PubMed  CAS  Google Scholar 

  30. Jungholm K., Kallen A., Persson C.G.A., Persson G., 1990, The anti-asthma efficacy of xanthines added to regimens of nonglucocorticoid and glucocorticoid therapies, Eur Respir J, (in press).

    Google Scholar 

  31. Lofdahl C.G., Chung K.F., 1991, Long-acting beta2-adrenoreceptor agonists: a new perspective in the treatment of asthma, Eur Respir J, 4:218.

    PubMed  CAS  Google Scholar 

  32. Lofdahl C-G., Svedmyr N., 1989, Formoterol fumarate, a new beta2-adrenoreceptor agonist, Allergy, 44:264.

    Article  PubMed  CAS  Google Scholar 

  33. Lunell E., Svedmyr N., Andersson K.E., Persson C.G.A., 1983, A novel bronchodilator xanthine apparently without antagonism and tremorogenic effect, Eur J Resp Dis, 64:333.

    CAS  Google Scholar 

  34. McAlpine L.G., Thomson N.C., 1990, Prophylaxis of exercise-induced asthma with inhaled formoterol, a long-acting beta2adrenergic agonist, Respiratory Medecine, 84:293.

    Article  CAS  Google Scholar 

  35. Magnussen H., Reuss G., Jorres R., 1987, Theophylline has a dose related effect on the airway response to inhaled histamine and methacholine in asthmatics, Am Rev Respir Dis, 136:1163.

    Article  PubMed  CAS  Google Scholar 

  36. Malo J-L., Cartier A., Trudeau C., Ghezzo H., Gontovnick L., 1990, Formoterol, a new inhaled beta2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction, Am Rev Resp Dis, 142:1147.

    PubMed  CAS  Google Scholar 

  37. Mann J.S., Holgate S.T., 1985, Specific antagonism of adenosine induced bronchoconstriction in asthma by oral theophylline, Br J Clin Pharmacol, 19:85.

    Article  Google Scholar 

  38. Mapp C., Boshetto P., Dal Veccho L., Crescioli S., De Marzi N., Paleari D., Fabbri L.M., 1987, Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects, Am Rev Respir Dis, 136:1403.

    Article  PubMed  CAS  Google Scholar 

  39. Nassif E.G., Weinberger M., Thompson R., Huntley W., 1981, The value of maintenance theophylline in steroid-dependent asthma, N Engl J Med, 304:71.

    Article  PubMed  CAS  Google Scholar 

  40. O’donneli S.R., Erjefalt I., Persson C.G.A., 1990, Early and late tracheobronchial plasma exsudation by platelet activating factor administered to the airway mucosal surface in guinea-pigs: effect of WEB 2086 and enprofylline, J Pharmacol Exp Ther, 254:65.

    Google Scholar 

  41. Pauwels R., Van Renterghem D., Van Der Straeten M., Johannesson N., Persson C.G.A., 1985, The effect of theophylline and enprofylline on allergen-induced bronchoconstriction, J Allergy Clin Immunol, 76:583.

    Article  PubMed  CAS  Google Scholar 

  42. Pauwels R.A., Persson C.G.A., 1991, Xanthines, In: Asthma. Its pathology and treatment. Ed by Kaliner MA, Barnes PJ, Persson CGA. Lung biology in health and disease, volume 49. Marcel Dekker, New York, pp 503–552.

    Google Scholar 

  43. Peel E.T., Gibson G.J., 1980, Effect of long-term inhaled salbutamol therapy on the provocation of asthma by histamine, Am Rev Resp Dis, 121:93.

    Google Scholar 

  44. Perruchoud A.P., Yerger L., Abraham W., 1984, Differential effect of aminophylline on the early and late antigen-induced bronchial obstruction in allergic sheep, Respiration, 46:44.

    Google Scholar 

  45. Persson C.G.A., Erjefalt, 1982, Seizure activity in animals given enprofylline and theophylline, two xanthines with partly different mechanisms of action, Arch Int Pharmacodyn Ther, 258:267.

    PubMed  CAS  Google Scholar 

  46. Persson C.G.A., Gustafsson B., 1986, Tracheal relaxation of combinations between xanthines and between a betat-receptor agonist and xanthines, Lune, 164:33.

    Article  CAS  Google Scholar 

  47. Persson C.G.A., Karlsson J.A., 1987, In vitro respones to bronchodilator drugs, In: Jenne J.W., Murphy S. (eds). Drug therapy for asthma. Research and clinical practice. Dekker, New York, pp 129–176.

    Google Scholar 

  48. Persson C.G.A., Pauwels R.A., 1991, Pharmacology of anti-asthma xanthines, In: Handbook of experimental pharmacology, vol 98, Pharmacology of asthma, Ed by CP Page and PJ Barnes, Springer-Verlag, Berlin, Heidelberg, pp 207–225.

    Google Scholar 

  49. Phillips G.D., Finnerty J.P., Holgate S.T., 1990, Comparative protective effectof the inhaled beta2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine and adenosine 5’-monophosphate in asthma, J Allergy Clin Immunol, 85:755.

    Article  PubMed  CAS  Google Scholar 

  50. Pollock J., Kiechel F., Cooper D., Weinberger M., 1977, Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn, Pediatrics, 60:840.

    PubMed  CAS  Google Scholar 

  51. Rabe K.F., Chung K.F., 1991, The challenge of long-acting betaadrenoreceptor agonists, Respiratory Medicine, 85:5.

    Article  PubMed  CAS  Google Scholar 

  52. Racineaux J.L., Troussier J., Turcant J., Tuchais E., Allain P., 1982, Comparison of bronchodilation effect of salbutamol and theophylline, Bull Eur Physiopathol Respir, 17:799.

    Google Scholar 

  53. Raes M., Mulder P., Kerrebijn K.F., 1989, Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma, J Allergy Clin Immunol, 84:874.

    Article  PubMed  CAS  Google Scholar 

  54. Ruffin R., Bryant D., Burdon J., Marlin G., Mitchell C., O’hehir R., Wilson J., Woolcock A., Webb S., 1988, Comparison of the effects of nebulized terbutaline with intravenous enprofylline in patients with acute asthma, Chest, 93:510.

    Article  PubMed  CAS  Google Scholar 

  55. Sears M.R., Taylor D.R, Print C.G, Lake D.C., Li Q., Flannery E.M., Yates D.M., Lucas M.K., Herbison C.P., 1990, Regular inhaled beta-agonist treatment in bronchial asthma, Lancet, 336:1391.

    Article  PubMed  CAS  Google Scholar 

  56. Shepherd G.L., Hetzel M.R., Clark T.J.H., 1981, Regular versus symptomatic aerosol bronchodilator treatment of asthma, Brit J Dis Chest, 75:215.

    Article  PubMed  CAS  Google Scholar 

  57. Svedmyr N., 1988, Xanthines, In: Asthma: Basic Mechanisms and Clinical Management. Ed by PJ Barnes, IW Rodger, NC Thomson, Academic Press, London, pp 607–625.

    Google Scholar 

  58. SWEDISH SOCIETY OF CHEST MEDECINE, 1990, High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma, Eur Respir J, 3:163.

    Google Scholar 

  59. Tattersfield A.E., Britton J.R., 1988, Beta-adrenoreceptor agonists, In: Asthma: Basic Mechanisms and Clinical Management. Ed by PJ Barnes, IW Rodger, NC Thomson, Academic Press, London, pp 563–590.

    Google Scholar 

  60. Tattersfield A.E., Holgate S.T., Harvey J.E., Gribbin H.R., 1983, Is asthma due to partial beta-blockade of airways ? Agents and Actions, 13:265–271.

    Article  PubMed  CAS  Google Scholar 

  61. Tattersfield A.E., Holgate S.T., Harvey H.E., Gribbin H.R., 1983, Is asthma due to partial beta-blockade of airways ? Agents and Actions, 13:265–271.

    Article  PubMed  CAS  Google Scholar 

  62. Tokuyama K., Lotvall J.O., Lofdahl C-G., Barnes P.J., Holgate S.T., 1990, Protection against allergen-induced asthma by salmetrol, Lancet, ii:1338.

    Google Scholar 

  63. Ullman A., Svedmyr N., 1988, Salmeterol, a new long-acting inhaled betaz-adrenoreceptor agonist: comparison with salbutamol in adult asthmatic patients, Thorax, 43:674.

    Article  PubMed  CAS  Google Scholar 

  64. Ullman A., Redner J., Svedmyr N., 1990, Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis, Am Rev Resp Dis, 142:571.

    Article  PubMed  CAS  Google Scholar 

  65. Vandewalker M.L., Kray K., Weber R.W., Nelson H.S., 1986, Addition of terbutaline to optimal theophylline therapy: double-blind cross over study in asthmatic patients, Chest, 90:198.

    Article  PubMed  CAS  Google Scholar 

  66. Vathenen A.S., Knox A.J., Higgins B.G, Britton J.R., Tattersfield A.E., 1988, Rebound increase in bronchial responsiveness after pretreatment with inhaled terbutaline, Lancet, 1:554.

    Article  PubMed  CAS  Google Scholar 

  67. Vilsvik J.S., Persson C.G.A., Amundsen T., 1990, Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma, Eur Respir J, 3:27.

    PubMed  CAS  Google Scholar 

  68. Wallin A., Melander B., Rosenhall L., Sandstrom T., Wahlander L., 1990, Formoterol, a new long-acting beta2-agonist for inhalationtwice daily, compared with salbutamol in the treatment of asthma, Thorax, 45:259.

    Article  PubMed  CAS  Google Scholar 

  69. Weinberger M., 1984, Pharmacology and therapeutic use of theophylline, J Allergy Clin Immunol, 73:525.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Diseases, University Hospital, De Pintelaan 185, B-9000, Ghent, Belgium

    Guy F. Joos & Romain A. Pauwels

Authors
  1. Guy F. Joos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Romain A. Pauwels
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Parma, Parma, Italy

    D. Olivieri

  2. National Heart and Lung Institute, London, UK

    P. J. Barnes

  3. National Institutes of Health, Bethesda, Maryland, USA

    S. S. Hurd

  4. University of Milan, Milan, Italy

    G. C. Folco

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Joos, G.F., Pauwels, R.A. (1992). Sympathomimetics and Xanthines in the Treatment of Asthma. In: Olivieri, D., Barnes, P.J., Hurd, S.S., Folco, G.C. (eds) Asthma Treatment. NATO ASI Series, vol 229. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3446-4_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3446-4_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6525-9

  • Online ISBN: 978-1-4615-3446-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation